Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2018-09-18 00:58 2018-09-13 ANGI Angi Inc. Luxor Capital Group, LP 10% owner Services-Advertising BUY $23.40 89,000 $2,082,208 618,527 +16.8%
2018-09-17 15:22 2018-09-13 FOLD AMICUS THERAPEUTICS, INC. PERCEPTIVE ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $11.74 100,000 $1,174,000 20,624,424 +0.5%
2018-09-17 22:00 2018-09-13 BHC Bausch Health Companies Inc. DE SCHUTTER RICHARD U Director Pharmaceutical Preparations BUY $23.96 125,000 $2,995,000 259,727 +92.8%
2018-09-15 02:16 2018-09-12 XXXX N/A American Beacon Advisors, Inc. 10% owner, Other Other BUY $10.00 500,000 $5,000,000 510,000 +5,000.0%
2018-09-15 01:30 2018-09-12 GCP N/A Dalbergia Investments LLC 10% owner Other BUY $25.03 478,252 $11,971,126 3,406,422 +16.3%
2018-09-15 00:09 2018-09-12 GTT N/A SPRUCE HOUSE PARTNERSHIP LP 10% owner Other BUY $43.10 328,000 $14,137,390 9,612,067 +3.5%
2018-09-14 15:30 2018-09-12 FOLD AMICUS THERAPEUTICS, INC. PERCEPTIVE ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $12.00 500,000 $6,001,500 20,524,424 +2.5%
2018-09-14 23:30 2018-09-12 BDGE Dime Community Bancshares, Inc. /NY/ BASSWOOD CAPITAL MANAGEMENT, L.L.C. Director, 10% owner, Other National Commercial Banks BUY $35.35 41,303 $1,459,987 652,970 +6.8%
2018-09-14 00:40 2018-09-12 KDP Keurig Dr Pepper Inc. Sceppaguercio-Gever Maria A. Officer - Chief Corp. Affairs Officer Beverages BUY $23.91 49,638 $1,186,641 113,861 +77.3%
2018-09-14 00:25 2018-09-12 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $46.66 24,517 $1,143,934 12,005,017 +0.2%
2018-09-13 21:04 - ENLK N/A GOLDMAN SACHS GROUP INC 10% owner Other BUY $18.74 433,421 $8,120,489 474,731 +1,049.2%
2018-09-13 01:22 2018-09-10 MGY Magnolia Oil & Gas Corp Walker John B Director, 10% owner Crude Petroleum & Natural Gas BUY $13.76 160,000 $2,201,696 160,000 +100.0%
2018-09-13 02:11 2018-09-10 KALV KalVista Pharmaceuticals, Inc. Cha Albert Director Pharmaceutical Preparations BUY $17.00 1,058,824 $18,000,008 1,359,149 +352.6%
2018-09-13 00:09 2018-09-05 TPB Turning Point Brands, Inc. Standard General L.P. 10% owner Tobacco Products BUY $34.60 153,079 $5,296,533 553,079 +38.3%
2018-09-13 02:16 2018-09-10 KALV KalVista Pharmaceuticals, Inc. ORONSKY ARNOLD L Director Pharmaceutical Preparations BUY $17.00 58,824 $1,000,008 388,766 +17.8%
2018-09-12 23:43 2018-09-10 BDGE Dime Community Bancshares, Inc. /NY/ BASSWOOD CAPITAL MANAGEMENT, L.L.C. Director, 10% owner, Other National Commercial Banks BUY $35.75 49,891 $1,783,359 613,083 +8.9%
2018-09-12 01:57 2018-09-07 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $46.60 101,594 $4,734,189 11,980,500 +0.9%
2018-09-12 00:16 2018-09-10 ETE Energy Transfer LP Brannon Richard D Director Natural Gas Transmission BUY $17.68 100,000 $1,767,900 172,619 +137.7%
2018-09-12 02:59 2018-09-09 BKTI BK Technologies Corp Fundamental Global Investors, LLC Director, 10% owner Radio & Tv Broadcasting & Communications Equipment BUY $3.95 692,534 $2,735,509 697,230 +14,747.3%
2018-09-10 23:47 2018-09-07 ADAP Adaptimmune Therapeutics PLC Behbahani Ali Director Biological Products, (No Diagnostic Substances) BUY $1.67 12,000,000 $20,000,400 12,000,000 +100.0%
2018-09-10 23:47 2018-09-07 ADAP Adaptimmune Therapeutics PLC Florence Anthony A. Jr. 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-10 23:49 2018-09-07 ADAP Adaptimmune Therapeutics PLC Sonsini Peter W. 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-10 23:45 2018-09-07 ADAP Adaptimmune Therapeutics PLC New Enterprise Associates 14, L.P. 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 3,000,000 $5,000,100 82,978,668 +3.8%
2018-09-10 23:49 2018-09-07 ADAP Adaptimmune Therapeutics PLC Viswanathan Ravi 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-11 00:21 2018-09-06 GTT N/A SPRUCE HOUSE PARTNERSHIP LP 10% owner Other BUY $41.88 702,531 $29,423,965 9,284,067 +8.2%
2018-09-10 23:46 2018-09-07 ADAP Adaptimmune Therapeutics PLC BASKETT FOREST 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-10 23:49 2018-09-07 ADAP Adaptimmune Therapeutics PLC SANDELL SCOTT D 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-10 23:48 2018-09-07 ADAP Adaptimmune Therapeutics PLC KERINS PATRICK J 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 3,000,000 $5,000,100 82,978,668 +3.8%
2018-09-10 23:48 2018-09-07 ADAP Adaptimmune Therapeutics PLC MOTT DAVID M Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-10 23:45 2018-09-07 ADAP Adaptimmune Therapeutics PLC BARRETT M JAMES 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 3,000,000 $5,000,100 82,978,668 +3.8%
2018-09-11 00:46 2018-09-06 VTVT vTv Therapeutics Inc. PERELMAN RONALD O 10% owner Pharmaceutical Preparations BUY $1.33 1,879,699 $2,500,000 6,778,470 +38.4%
2018-09-11 01:26 2018-09-07 ETP N/A WARREN KELCY L Director, Officer - Chief Executive Officer Other BUY $22.42 2,000,000 $44,848,800 4,287,442 +87.4%
2018-09-10 23:31 2018-09-06 SAFE N/A ISTAR INC. 10% owner Other BUY $16.35 129,600 $2,118,960 7,387,410 +1.8%
2018-09-10 23:46 2018-09-07 ADAP Adaptimmune Therapeutics PLC BARRIS PETER J 10% owner Biological Products, (No Diagnostic Substances) BUY $1.67 15,000,000 $25,000,500 12,000,000 +100.0%
2018-09-07 23:51 2018-09-06 TIF N/A Trapani Francesco Director Other BUY $124.25 40,000 $4,970,140 500,000 +8.7%
2018-09-08 02:55 2018-09-05 AMR N/A BAYOU CITY ENERGY MANAGEMENT LLC Director, 10% owner Other BUY $4.73 311,111 $1,472,551 4,133,911 +8.1%
2018-09-07 23:39 2018-09-05 TPB Turning Point Brands, Inc. Standard General L.P. 10% owner Tobacco Products BUY $34.60 153,079 $5,296,533 10,395,452 +1.5%
2018-09-07 15:31 2018-09-06 AGN N/A COUGHLIN CHRISTOPHER J Director Other BUY $190.64 10,000 $1,906,394 16,431 +155.5%
2018-09-08 02:25 2018-09-06 BLDR Builders FirstSource, Inc. LEVY PAUL S Director Retail-Lumber & Other Building Materials Dealers BUY $15.98 100,000 $1,598,000 1,117,984 +9.8%
2018-09-07 00:11 2018-09-04 OCPIX N/A OppenheimerFunds, Inc. 10% owner Other BUY $10.01 749,251 $7,500,000 3,745,753 +25.0%
2018-09-07 00:42 2018-09-04 AMH American Homes 4 Rent HUGHES B WAYNE ET AL Director Real Estate Investment Trusts BUY $23.01 217,000 $4,993,344 13,889,346 +1.6%
2018-09-07 00:17 2018-09-04 OCPIX N/A TC Group Cayman Investment Holdings, L.P. 10% owner Other BUY $10.01 749,251 $7,500,000 3,748,751 +25.0%
2018-09-07 00:45 2018-09-05 AMH American Homes 4 Rent GUSTAVSON TAMARA HUGHES Director Real Estate Investment Trusts BUY $22.93 217,000 $4,976,852 15,803,898 +1.4%
2018-09-07 00:49 2018-09-06 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $46.86 76,535 $3,586,430 11,878,906 +0.6%
2018-09-07 01:06 2018-09-04 BDGE Dime Community Bancshares, Inc. /NY/ BASSWOOD CAPITAL MANAGEMENT, L.L.C. Director, 10% owner National Commercial Banks BUY $35.23 38,521 $1,357,226 540,653 +7.7%
2018-09-06 00:01 2018-08-31 LOACU N/A Chen Matthew Director, Officer, 10% owner - CEO and Chairman Other BUY $10.00 250,000 $2,500,000 1,400,000 +21.7%
2018-09-05 23:30 2018-08-31 TIF N/A Trapani Francesco Director Other BUY $122.96 15,000 $1,844,337 460,000 +3.4%
2018-09-05 01:44 2018-09-04 WFCF Where Food Comes From, Inc. Rein Graeme P. Director, 10% owner Services-Prepackaged Software BUY $1.90 950,000 $1,805,000 2,665,210 +55.4%
2018-09-04 23:11 2018-08-30 VNE N/A Carlson Jan Director, Officer - Chief Executive Officer Other BUY $50.65 50,000 $2,532,500 50,000 +100.0%
2018-09-05 01:27 2018-08-31 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $46.71 96,422 $4,504,267 11,802,371 +0.8%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.